Singapore, 12 OCT 2020 │Improving Medical Practices in Clinical Treatment
DCH Auriga Singapore hosted 4 engaging webinars recently through our IMPACT multi-topic virtual series, which empowers healthcare professionals to improve medical practices through advancements in clinical treatment.
During uncertain times, when everyone must do their part by staying at home to curb the spread of COVID-19, DCH Auriga recognizes the need and importance for continuous healthcare education to be in place, especially when healthcare updates and changes evolve quickly. We took the initiative and created opportunities to invite experts in their respective fields from all around the globe to share their personal clinical best practices.
Throughout the month of August till September, over 400 healthcare professionals consisting of Dermatologists, General Practitioners, Aesthetic Doctors, Surgeons, and many others attended these webinars with very positive feedback. The event hosted attendees from around the world with global participants from Singapore, Romania, China, Thailand, Australia and more. As a highlight, following each presentation, event attendees were given the opportunity to further engage with the speakers through a separate Q&A session.
IMPACT Multi-Topic Virtual Series cover a wide variety of topics ranging from updates in the management of irritable bowel syndrome, supporting liver function in non-alcoholic fatty liver disease, as well as dermatology and aesthetic treatments.
DCH Auriga Singapore would like to thank our exceptional speakers, Dr. Wang Yu Tien, Dr. Leon H. Kircik, Dr. Mark Tang, Professor Alberto Beretta, Professor Jorn Schattenberg, Professor Leonardo Marini and Mr. Eduardo Serrano for taking the time to share their knowledge and experiences.
With more exciting IMPACT webinars in the pipeline, DCH Auriga will continue to create strong presence and further our commitment in developing impactful and enriching experiences for healthcare professionals.
For further information, please contact:
DCH Auriga Singapore
Rahul Menon, Manager – Pharmaceuticals | +65 8518 5600 | [email protected]
About DCH Auriga
DCH Auriga is an Asia-based integrated market management provider specializing in healthcare.
The company is headquartered in Hong Kong, a Dah Chong Hong Company with 50+ years of experience and operations in Hong Kong, Macau, China, Singapore, Malaysia, Brunei, Indonesia, Vietnam, Thailand and the Philippines. Offering comprehensive commercial and logistics solutions, DCH Auriga partners with the world’s leading healthcare companies to distribute pharmaceuticals, medical devices, surgical equipment, diagnostics and OTC products for 500+ brands into 10,000+ hospitals, pharmacies and specialty stores across Asia.
Dah Chong Hong Holdings (DCH) is an integrated motor and consumer products distribution company operating in Asia with an extensive logistics network. Dedicated to bringing quality products to consumers across Asia, DCH is the preferred partner of over 1,000 brands from more than 30 countries with operations in 12 Asian economies. DCH is a subsidiary of China’s largest conglomerate, CITIC Limited (stock code: 00267) and employs 17,000 staff across the region.
DCH Auriga News (English): https://www.dchauriga.com/en/news-and-insights/
DCH Auriga News (Chinese): https://www.dchauriga.com/hk/news-and-insights/
DCH Auriga LinkedIn: https://www.linkedin.com/company/dchauriga/
DCH Auriga Facebook: https://www.facebook.com/DCH-Auriga-1720751151308531/
DCH Auriga, its affiliates, and employees, will not be held responsible for any injuries, disease, or death from the use of the products. For the avoidance of doubt, the products are not intended to diagnose, treat, cure, or prevent any disease or health condition.